Pharmacy Braduate leading the way

Studying at Bradford was a time of discovery for Paul, laying the foundation for his lifelong interest in science, which he has carried through into his working life. His passion for improving people’s health and supporting the development of pharmacy drives his vision for the RPS in confronting the challenges and opportunities facing the profession. “It’s our role to open up the opportunities for pharmacists to get into new areas of practice, while not forgetting those who choose to practice in the more traditional areas such as community pharmacy, which can contribute to improved healthcare and patient outcomes. We’ve done an awful lot of work around creating new opportunities for pharmacists in GP practice, pharmacists in emergency care units and pharmacists in care homes, and I’m very keen on pursuing an agenda where pharmacists can help improve the health of patients in the primary care setting as well as helping pharmacists in secondary care who want to focus upon various specialisations like gene therapy.”

“This is a really exciting area, some of which has been touched on in my visit here to the University today, and the RPS needs to help pharmacists who want to operate in those areas and pursue those opportunities. This is about the advancement of the profession and our role as a leadership body is to unlock those opportunities and work with all relevant stakeholders to create new possibilities for pharmacists as professionals to practice their profession. I am enjoying marshalling the fantastic team at the Society to deliver these objectives.” Complementing these new ways of working are the advancements in teaching and learning, which Paul was able to see for himself during his visit to Bradford: “In terms of preparing students to be the future pharmacists that we so much need and encourage, Bradford is well placed to do that. There is a lot more team-based learning, exposing students to the environment in which they will practice in future. The application of technology at Bradford is clearly a major positive in helping students to learn and develop, and coupled with the modern teaching methods in use, Bradford feels like it’s got a very strong and positive future.”

Paul has gained a wealth of professional and commercial experience from both national and local pharmacy organisations alongside strong leadership credentials from business and from close working with NHS Commissioners of service. This has helped him make the transition to his position as Chief Executive with the RPS, a role he describes as taxing but thoroughly enjoyable. Paul is keen that all graduates and pharmacy professionals see the benefit of joining a membership body but admits that the challenge is a significant one. “Pharmacists have a choice whether to be members of the RPS or not and it’s, therefore, our job to demonstrate the compelling reasons why being a member of your professional leadership body is the right thing to do.”

“We have to stay grounded in what it is that our members expect of us and to make sure that we deliver the things that they need. Whether it be the development and publication of professional standards, whether it is around education, learning and support, whether it be around professional guidance, or whether it’s around our advocacy role - we’ve got to be where members want us to be and doing what they want us to do while being seen to do that with energy and at pace.”

“At the Society we have a number of immediate priorities, one of those is around the introduction of revalidation by the General Pharmaceutical Council, the regulatory body of the profession, which is a new approach looking at how pharmacists can remain as competent practitioners and the RPS is leading in this space to help support pharmacists meet the new regulatory requirements that come in to play this year. We will also be looking at our international strategy in more depth. The RPS has a very strong and proud reputation not only within Great Britain, our main footprint but globally. We have very strong credentials in pharmaceutical publishing and we’ll maintain that position in the UK while we also reach out into different global markets. At the end of the day, any commercial success from our activities will be reinvested in supporting our members because we are first and foremost a membership and leadership organisation.”